New Medical Coding Procedures At Clinical CRO ICRC-Weyer

The clinical contract research organization (CRO) ICRC-Weyer GmbH, based in Berlin, Germany, has changed its coding procedures for medications, enabling the company to offer enhanced solutions to a broad client base.

(firmenpresse) - ICRC-Weyer GmbH has announced an enhancement to their medical coding procedures for drug development processes.

Until recently, the company had been utilizing limited licenses for the coding dictionary of the World Health Organization WHO (WHO DD/WHO Drug). WHO DD is an international classification of medicines created by the WHO Programme for International Drug Monitoring and managed by the Uppsala Monitoring Centre. It is used by pharmaceutical companies, clinical trial organizations and drug regulatory authorities for identifying drug names in spontaneous ADR reporting and in clinical trials. There have been major developments in the form of a WHO DD Enhanced (with considerably more fields and data entries) and a WHO Herbal Dictionary, which covers traditional and herbal medicines.

ICRC-Weyer GmbH has now switched to a full, unlimited license of WHO Drug, including the above mentioned Enhanced and Herbal extensions. This enables the company to offer even more versatile and powerful medical coding solutions to a wider range of clients.

All coding at ICRC-Weyer is carried out and controlled within their specialist Medical Data Management department, staffed exclusively by medically trained experts.

Aside from WHO DD, ICRC-Weyer also offers medication coding purely within the WHO ATC classification system, as well as MedDRA and other specialist dictionaries for coding of Adverse Events, medical histories, signs, symptoms, and diseases.

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Leseranfragen:
PresseKontakt / Agentur:
Bereitgestellt von Benutzer: icrc_weyer
Datum: 18.07.2012 - 17:20 Uhr
Sprache: Deutsch
News-ID 166530
Anzahl Zeichen: 1746

contact information:

Kategorie:

Healthcare & Medical

Typ of Press Release: Produktinformation
type of sending: Veröffentlichung

Diese Pressemitteilung wurde bisher 401 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"New Medical Coding Procedures At Clinical CRO ICRC-Weyer"
steht unter der journalistisch-redaktionellen Verantwortung von

ICRC-Weyer GmbH (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

ICRC-Weyer To Expand Pharmacovigilance Services For Mid-Sized Pharma Companies ...

In a move to better meet drug-safety related service requirements by small to mid-sized pharmaceutical sponsors ICRC-Weyer has expanded its services portfolio in regards to pharmacovigilance and pharmacovigilance writing. ‘Our pharmacovigilance ...

ICRC-Weyer To Boost Drug Safety Services For Investigator Trials ...

An increase in the number of requests by trial sponsors for regulatory-compliant drug safety reporting for investigator-initiated trials (IITs) has led the German CRO ICRC-Weyer to amend their services portfolio towards providing these services to la ...

ICRC-Weyer Joins CDISC®, Expands Data Management ...

As part of a continuous growth process, ICRC-Weyer has added further members to its data management team enabling the company to meet the increasing demand for a complete range of services for phase I-IV clinical trials as well as post-marketing stud ...

Alle Meldungen von ICRC-Weyer GmbH